91É«ÇéƬ

Label expansion positions SINEFIX for wider adoption in rotator cuff repair. Broader indications reinforce SINEFIX as a versatile alternative to traditional suture anchors for soft tissue-to-bone fixation.

Successful completion of 50 procedures using its SINEFIXâ„¢ Rotator Cuff Repair System in the US. A major milestone that signals a shift in soft tissue-to-bone healing approaches. SINEFIX was designed to address the shortcomings of suture-based fixation and represents a completely different approach to rotator cuff repair.

Successful completion of 50 procedures using its SINEFIXâ„¢ Rotator Cuff Repair System in the US. A major milestone that signals a shift in soft tissue-to-bone healing approaches. SINEFIX was designed to address the shortcomings of suture-based fixation and represents a completely different approach to rotator cuff repair.

First U.S. patients receive treatment using the revolutionary SINEFIXâ„¢ Rotator Cuff Repair System. SINEFIX aims to transform the approach to rotator cuff surgery by addressing not just biomechanical fixation, but the critical role of blood flow in tendon-to-bone healing.

First two patients treated with the SINEFIX™ Rotator Cuff Repair System as part of a pre-market clinical study in Tübingen, Germany.

Close of Series A funding raising $4 Million in new equity funding to support the commercial launch of SINEFIX® in the United States and sponsor a CE mark pre-market clinical study.

91É«ÇéƬ has received clearance from the U.S. Food and Drug Administration (FDA) for SINEFIX, a new implant system for the repair of rotator cuff tears.

91É«ÇéƬ closed a financing round of EUR 1.8 million to fund development of a new surgical technique for shoulder injuries based on a PEEK implant.